Clinical Trial Update: Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069 [Phase 1]

View source ↗

Summary

A Phase 1 study assessing safety, tolerability, and effects of multiple dosing with AZD 4721 and AZD 5069 in COPD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD 4721
• AZD 5069

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD). | Phase 1 | Status: COMPLETED